Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours
NCT01194193
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
63
Enrollment
INDUSTRY
Sponsor class
Stopped
Amendment to study compound development programme
Conditions
Cancer
Advanced Solid Tumours
Lymphomas
Interventions
DRUG:
AZD8055
Sponsor
AstraZeneca